English - FMC BioPolymer

Our commitment to:
• Innovate new product offerings
• Improve health and nutrition around the world
• Help our customers grow their business

Who Are We?
FMC BioPolymer is a global supplier of microcrystalline cellulose (MCC),
carrageenan, alginates, pectin and natural colors – sustainable ingredients
that have high value-added applications in the production of food,
pharmaceuticals, biomedical and other specialty consumer and
industrial products.
MCC, processed from specialty grades of renewable hardwood and softwood
pulp, provides binding and disintegrant properties for dry tablets and capsules
and has unique functionality that improves the texture and stability of many
food products. Carrageenan and alginates, both processed from natural
seaweed, are used in a wide variety of food, pharmaceutical and oral
care applications. BioPolymer also supplies other specialty ingredients for
solutions to our customers’ most important needs.
In addition, we are developing technology platforms within biomedical
markets to provide ultrapure biopolymers and application know-how for
biomedical devices.
FMC BioPolymer has 10 laboratories on four continents, including our newest
food lab in Singapore to support our rapidly expanding Southeast Asia market.
In one recent 12-month period alone, we launched 25 new food ingredient
products and are steadily introducing an expanding line
of health and nutrition ingredients derived
from brown seaweed.
FMC Vision 2015 is an exciting, bold strategy
focused on dramatically expanding FMC’s
global reach and adding more value to our
customers’ businesses.
Our employees are energized and committed to the success
of this strategy and we are eager to share its goals with
customers, partners and suppliers throughout our value chain.
To a significant extent, we all share in the challenges and
opportunities presented by this new vision.
For FMC BioPolymer, Vision 2015 is another chance to
strengthen our already strong, market-leading
positions in the pharmaceutical and food ingredient
sectors through new product offerings and new
chemistry applications for our existing products. Vision
2015 means we are becoming even more engaged with our
customers as long-term, vital partners in pursuing their
own growth strategies.
Many of our customers in the food and pharmaceutical
industries rely heavily on FMC for the majority of their supply
requirements that relate directly to our chemistry applications.
That’s because we are a dependable partner: We are
laser focused on maintaining consistent product quality and
relentless in creating innovative solutions that satisfy our
customers’ unique and shifting product development needs.
Forging these kinds of powerful, intimate customer
relationships on a global scale is very difficult for any
other company to imitate or replicate. It’s what we
call The Right Chemistry – and it’s the foundation
of our future growth. Together with our customers
in these fast-growing markets, we are helping
improve the health, nutrition, convenience
and product enjoyment for consumers
around the globe – and that’s precisely the
right chemistry for our mutual success.
www.fmcbiopolymer.com

Vision 2015:
Shared Across All FMC
Businesses
FMC BioPolymer is part of
FMC’s Specialty Chemicals
business, which also has
two sister businesses: FMC
Industrial Chemicals and FMC
Agricultural Products. Each
of these lines of business has
set similarly ambitious 2015
goals for FMC Corporation,
a world-class, diversified
specialty chemistry company.
We know that our continued
growth will come from
expanding our existing strong
leadership positions in key
markets while increasing our
reach in rapidly developing
economies, where demand is
steadily rising for our unique
chemistry applications.
Through a sustained
corporate culture of
innovation, integrity, safety,
sustainability, responsibility
and customer intimacy, we
intend to foster The Right
Chemistry in everything we
do as we passionately pursue
our Vision 2015 objectives.
Aiming High – For Us and Our Customers
Vision 2015 forecasts that our value-adding food
and pharmaceutical ingredients sales will more than
double compared to 2009. Given that we are already a
global innovator of these ingredients and a competitively
priced, premium supplier, we are achieving our vision by:
• Delivering superior value to customers
• Growing our market share in rapidly developing
economies (RDEs)
• Acquiring new products that expand our line of
chemistry solutions.
Our vision is also being met by enabling our customers to
go to market with new products that satisfy the exacting
demands of their customers. This, in turn, fosters their
continued growth and ever-expanding opportunities in the
marketplace.
To support our goals, we are investing in our core
businesses to maintain our position as a high-quality,
premium supplier. We are adding new capacity, new
capabilities and new innovation strategies to improve our
products, services and speed to market for our customers.
As part of the much larger family of FMC businesses, we are
also leveraging the size and scale of our global company
through more efficient and effective procurement processes,
regional infrastructure consolidation and a more nimble
presence in local markets. This effort to operate as “one
FMC” is reaping long-term benefits for our business and
our customers.
BioPolymer Outlook: Food
In the food sector, we serve the texture, structure and
physical stability (TSPS) food ingredients market – providing
ingredients that thicken and stabilize foods, including meats,
dairy, bakery and convenience foods. Our customers range
from global brand leaders to regional food manufacturers.
Trends that are advancing our growth include rising
consumer desire for healthier foods and greater
convenience, as well as increases in per capita consumption
of processed foods in emerging markets. The move toward
health and convenience drives the need for more functional
ingredients to deliver on consumers’ expectations for desired
texture and enjoyment. Because FMC BioPolymer chemistries
directly address these needs and because our solutions are so
unique, we are growing faster than the overall TSPS market.
proven market leaders who can help them reduce costs,
leverage existing technology and expand product offerings
among their key accounts. We are proactively addressing the
changing needs of this consolidating customer base.
We work in every region, shoulder to shoulder with
our customers, to help them launch new products and
reformulate existing ones. The regional nature of the food
business means that we must have different solutions for
customers in China versus those in India, Turkey or the
United States. Our innovative approach in identifying new
applications and new end markets is a critical differentiator
that favors our success.
BioPolymer Outlook: Pharmaceuticals
Our chemistry is mostly unnoticed by end-consumers but is
an essential component in the practical consumption
of many pharmaceuticals. For FMC BioPolymer, demand
for our chemistry parallels consumers’ ever-increasing health
consciousness and the need for medicines to manage acute
or chronic pain, particularly as average life spans continue
to rise. Coupled with demand growth in rapidly developing
economies, the market indicators for this sector are
highly attractive.
While we do not manufacture drugs, vitamins or nutritional
supplements, we are a long-time leader in helping the
pharmaceutical industry create and market consumable
products from renewable biopolymers. We provide formulation
ingredients that function as binders, disintegrants, suspending
agents, and controlled-release compounds in the production of
both solid and liquid pharmaceutical products.
Another significant trend over the past several years
is consolidation among our food customers and these
transformed enterprises strongly prefer relationships with
www.fmcbiopolymer.com

In addition, we have developed and commercialized new soft
capsule technology that utilizes carrageenan. These new
capsules are being used for vitamins and other supplements.
And our ultrapure biopolymers have numerous biomedical
applications, including tissue engineering, cell encapsulation,
and medical devices.
Vision 2015 Strategy
Food Ingredients
We are meeting our customers’ sharply rising global product development needs through innovative ingredient
solutions. As a result, we expect to more than double our total sales compared to 2009.
FMC BioPolymer customers depend on the successful
therapeutic performance of their drug products, so they turn
to us to deliver the most reliable and broadest range of novel
product uses.
We also supply alginates, microcrystalline cellulose (MCC)
and carrageenan into the oral care, cosmetics and health
care markets. Highly refined extracts from selected seaweeds
provide a wide range of alginate uses, including antireflux,
dental impressions, and wound dressings. Special grades of
our carrageenan extracts are used in liquid cough medicines,
toothpaste and a variety of skin care products.
Opportunities for Growth
• Greater consumer focus on health and nutrition
• Higher demand for convenience foods
• Rising incomes, especially in rapidly
developing economies
• Demand for more value
Our Strategy
• Invest in our core products and chemistry
innovations to bolster our leadership position
• Provide new food texture solutions to our
current customers
• Invest in rising growth markets
• Pursue higher growth, high value-added
ingredients
The Path Forward
FMC BioPolymer has a strong legacy of customer intimacy
that springs from our desire to tackle any challenge,
solve any problem and exceed every expectation.
Vision 2015 doubles down on that commitment to help our
customers succeed and grow in an exciting era of change and
opportunity. It’s The Right Chemistry for all of us.
Pharmaceutical Ingredients
We are building on our position as a leading value-added supplier, providing enabling solutions for active
pharmaceutical ingredients. We expect our sales to more than double from 2009 levels.
Opportunities for Growth
Our Strategy
• Aging populations with rising access to medicines
• Increased use of generic drugs
• Rising demand for lower costs and higher value
• Strong upward demand from rapidly developing
economies
• Invest in our core products to maintain our
position as a premium supplier
• Broaden our innovation and customer
service focus
• Expand the use of our tablet excipient
technologies
• Increase our participation in broader dosage
forms to reach larger, faster-growing markets
FMC BioPolymer Products Serving
Pharmaceutical & Food Customers
Avicel ® Gelcarin ®
Avicel ® PH Lattice ®
Avicel ® DG Manucol ®
Avicel ® HFE Manugel ®
Avicel ® CE Novagel ®
Ac-Di-Sol ® Protanal ®
Alubra Seakem ®
Aquacoat ® Viscarin ®
www.fmcbiopolymer.com

FMC Corporation
1735 Market Street
Philadelphia, PA 19103
www.fmcbiopolymer.com
(215) 299.6000